Evidence map›Paper›PMID 21760613›Full record

ArticleEMBO reports2011

Progressive methylation of ageing histones by Dot1 functions as a timer.

Dirk De Vos, Floor Frederiks, Marit Terweij, Tibor van Welsem, Kitty F Verzijlbergen, Ekaterina Iachina, Erik L de Graaf, A F Maarten Altelaar, Gideon Oudgenoeg, Albert J R Heck and 3 more

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Connecting the DOTs on Cell Identity.Frontiers in cell and developmental biology · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Dirk De VosDepartment of Molecular Cell Physiology, Vrije Universiteit, Amsterdam, The Netherlands.
Floor Frederiks
Marit Terweij
Tibor van Welsem
Kitty F Verzijlbergen
Ekaterina Iachina
Erik L de Graaf
A F Maarten Altelaar
Gideon Oudgenoeg
Albert J R Heck
Jeroen Krijgsveld
Barbara M Bakker
Fred van Leeuwen
Utrecht University · NLThe Netherlands Cancer Institute · NLOncode Institute · NLCancer Genomics Centre · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications of histone proteins have a crucial role in regulating gene expression. If efficiently re-established after chromosome duplication, histone modifications could help propagate gene expression patterns in dividing cells by epigenetic mechanisms. We used an integrated approach to investigate the dynamics of the conserved methylation of histone H3 Lys 79 (H3K79) by Dot1. Our results show that methylation of H3K79 progressively changes after histone deposition, which is incompatible with a rapid copy mechanism. Instead, methylation accumulates on ageing histones, providing the cell with a timer mechanism to directly couple cell-cycle length to changes in chromatin modification on the nucleosome core.

Indexed as

AgingCell CycleChromatinGene Expression Regulation, FungalHistone-Lysine N-MethyltransferaseHistonesMethylationNuclear ProteinsNucleosomesProtein Processing, Post-TranslationalSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsChromatinDot1 protein, S cerevisiaeHistone-Lysine N-MethyltransferaseHistonesNuclear ProteinsNucleosomesSaccharomyces cerevisiae Proteins

Identifiers

PMID21760613
PMCPMC3166457
OpenAlexW2145096973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.